Equities research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the stock.
Ayala Pharmaceuticals Trading Up 1.9 %
ADXS opened at $0.55 on Wednesday. The stock has a market capitalization of $5.91 million, a P/E ratio of -0.07 and a beta of 1.62. Ayala Pharmaceuticals has a 12 month low of $0.50 and a 12 month high of $1.95. The firm’s fifty day simple moving average is $0.69 and its 200 day simple moving average is $0.74.
Ayala Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ayala Pharmaceuticals
- What is a Dividend King?
- Hasbro’s Management Made All the Right Calls This Quarter
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What Are Dividends? Buy the Best Dividend Stocks
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.